Skip to content

A clinical study on magnetic resonance elastography for hepatocellular carcinoma patients

A clinical study on magnetic resonance elastography for assessing hepatic functional reserve of hepatocellular carcinoma patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DCD-15005799
Enrollment
Unknown
Registered
2014-12-18
Start date
2015-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cancer

Interventions

Gold Standard:
Index test:

Sponsors

The Second Affiliated Hospital of Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. clinical diagnosed hepatocellular carcinoma(EASL criteria)and prepare for interventional therapy; 2. liver tumor diameter less than 10cm; 3. volunteers(male/female) who signed content document and can obey our clinical observe; 4. The patients who can cooperate MR scan so that we can acquire high quality imaging data; 5. The patients who need liver functional reserve test to prepare for interventional therapy; 6. The patients who have no contraindication for liver functional reserve test(indcoyanine green clearance test).

Exclusion criteria

Exclusion criteria: 1. liver tumor diameter over 10cm and have the risk of tumor rupture; 2. The patient who can not cooperate MR scan; 3. Iron overload in liver lead to MR signal decrease; 4. The patient who is inappropriate for liver functional reserve test.

Design outcomes

Primary

MeasureTime frame
liver stiffness;indocyanine green retention rate at 15 minute;indocyanine green plasma clearance rate;

Countries

China

Contacts

Public ContactBin Li
zrlibin@126.com+86 13588079261

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026